Table 2.
VWD diagnostic approaches
VWD diagnostic strategy | |
---|---|
Clinical phenotype | Increasing use of quantitative bleeding assessment tools; eg, ISTH-BAT |
Hemostasis laboratory | • VWF:Ag |
phenotype | • VWF:RCo: possibility of substituting a direct GPIb-binding assay |
• VWF:CB combination of collagens I and III | |
• VWF:F8 | |
• VWFpp: aids in identification of accelerated clearance variants | |
• VWF multimer profile | |
• Ristocetin-induced platelet agglutination (RIPA) | |
Genotype | • Type 1 VWD: premature for routine use, may be helpful in the future |
• Type 2A: not usually needed | |
• Type 2B: helpful confirmation and rules out PT-VWD | |
• Type 2M: sometimes helpful | |
• Type 2N: definitive differentiation from mild hemophilia A | |
• Type 3: very helpful for genetic counseling |
VWFpp indicates VWF propeptide; and PT-VWD, platelet-type VWD.